Central Drugs Standard Control Organization (CDSCO)

The Central Drugs Standard Control Organization (CDSCO) is India’s national regulatory authority responsible for regulating pharmaceuticals, medical devices, cosmetics, and healthcare products. Established under the Directorate General of Health Services (DGHS), Ministry of Health and Family Welfare, Government of India, CDSCO plays a vital role in ensuring the safety, quality, and effectiveness of healthcare products available in the country.

CDSCO is responsible for approving new drugs, regulating clinical trials, overseeing imported medicines, monitoring drug quality, and coordinating regulatory activities with India’s state drug control organizations. The organization operates through specialized divisions responsible for pharmaceutical evaluation, medical device regulation, biological products, vaccines, and regulatory compliance.

The authority evaluates new medicines, vaccines, biologics, and advanced therapies before approval while ensuring compliance with national and international quality standards. CDSCO also conducts inspections of pharmaceutical manufacturing facilities and monitors compliance with Good Manufacturing Practices (GMP).

The organization works closely with pharmaceutical companies, biotechnology companies, research institutions, healthcare professionals, and international regulatory agencies to strengthen India’s healthcare regulatory framework.

CDSCO provides regulatory guidance for clinical research, pharmaceutical innovation, medical devices, diagnostics, and emerging healthcare technologies. It also participates in global regulatory initiatives and works toward harmonization with international standards.

Through scientific assessment, regulatory oversight, and quality monitoring, CDSCO supports pharmaceutical innovation while protecting public health by ensuring that medicines and healthcare products meet required safety and effectiveness standards.

As India’s leading drug regulatory authority, CDSCO plays an essential role in supporting the growth of the pharmaceutical industry and maintaining confidence in healthcare products.